Audience · Pre-IPO

Frontier Alternatives Fund IPre-IPO Secondaries

Late-stage private-company secondary investments with negotiated pricing, liquidity discounts, capitalization and preference analysis, transfer restrictions, and potential exit pathways.

Confidential Qualified & Accredited Investors Manual review required
Explore by audience

Find your route

Institutional CapitalStructured alternative investments, distressed acquisitions, and co-investment structures for larger mandates. Litigation FinanceCommercial and arbitration funding, contractual-rights enforcement, and judgment-related opportunities. Family OfficeA diversified private-market alternatives mandate with selective frontier and pre-IPO secondaries. Accredited IndividualsEducation, risk awareness, and investor qualification for potentially eligible accredited individuals. Multi-StrategyHybrid, event-driven, and cross-strategy capital deployment across distressed and equity-linked instruments. Seed & Early StageFrontier technology seed investments — AI infrastructure, robotics, quantum, and founder-market fit. Pre-IPO SecondariesLate-stage private-company secondary positions with negotiated pricing and preference analysis. Special SituationsEngine 3's six distinct lanes — from warrant enforcement to large distressed acquisitions.
Selection principles

How we approach Pre-IPO

Illustrative structures

How capital can participate

Illustrative transaction structures only — no specific investments, issuers, or counterparties are named or implied. Final structures are set in definitive documentation.

Material risk considerations

Risk

Liquidity risk until an exit event; transfer-restriction risk; preference-stack dilution; IPO timing uncertainty; valuation reversal; possible total loss.

Participation is subject to suitability, legal documentation, and manual approval by AdValorem. No specific projected returns, committed allocations, investment minimums, or transaction economics are disclosed on this public page.

Request access

Start the conversation

Confidential Materials

Request Access & Start the Conversation

Complete the intake to request review. AdValorem will confirm your relationship and eligibility before releasing any confidential offering materials. Submission does not grant access.

Step 1 of 2 · Investor profile & relationship
Investor type
Existing relationship with AdValorem
Indicative investment range (non-binding)

Indicative only — not a commitment. Final eligibility and participation terms are set in definitive documentation.

Step 2 of 2 · Eligibility, interests, and representations
A · Accredited-investor basis — Rule 501(a)
B · Qualified-purchaser status — Section 2(a)(51)
C · Relationship evidence
D · Strategies & lanes of interest
E · Preferred capital participation structure
F · Brief message (optional)
G · Representations — all required

Reg D 506(b) materials. Submitting does not grant access. AdValorem will review eligibility, relationship, and representations before confidential access is granted. Under Rule 506(b), a submission, self-certification, or NDA does not by itself establish eligibility to receive an offering solicitation.

Submitted for review

Your eligibility and relationship details have been received. AdValorem will review your submission and follow up with next steps. You will be contacted if confidential access is approved.

← Back to the central FAF page

Reg D 506(b) Private Placement. This material is provided to a limited number of qualified and accredited investors. It is not an offer to sell, nor a solicitation to buy, any security. Any offering will be made solely through formal definitive documentation.

Eligibility & no automatic access. Participation is restricted to investors who meet the definition of "accredited investor" under Rule 501(a) of Regulation D and, where applicable, "qualified purchaser" under Section 2(a)(51). Under Rule 506(b), a submission, accreditation self-certification, checkbox, NDA, or password does not by itself establish that an investor can receive an offering solicitation. AdValorem performs a manual relationship and eligibility review; no access is granted automatically.

Forward-looking statements. Statements regarding strategy, pipeline, and market conditions are forward-looking and inherently subject to risks and uncertainties. No specific projected returns, committed allocations, investment minimums, or transaction economics are disclosed on this public page; those are provided only under counsel-approved, protected access.

Risk. Investments are speculative, long-duration, illiquid, and subject to enforcement, valuation, and liquidity risk. Investors may lose some or all of their committed capital.

Confidentiality. Confidential offering materials are not published on this site and are only released after manual review and approval, subject to securities-counsel guidance.